Author: News Room
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Venture To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Venture pursuant and/or traceable to Venture’s registration statement for the initial public offering held on or about January 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm,…
New York, NY, April 02, 2025 (GLOBE NEWSWIRE) — The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development. The new Center will integrate AI with traditional drug discovery methods to identify and design new small-molecule therapeutics with unprecedented speed and precision. Unlike conventional drug discovery, which can take years and cost billions, AI-driven approaches enable researchers to rapidly navigate a vast chemical landscape, including natural products, to pinpoint promising drug candidates. By leveraging Mount Sinai’s world-leading expertise in machine learning,…
Four ticket options available, including Early Access and Dash PassFestival runs April 12-13, from 9 a.m. to 5 p.m.; tickets available online and in person PHOENIX, April 02, 2025 (GLOBE NEWSWIRE) — Electrify Expo, North America’s largest electric vehicle (EV) and technology festival, is returning to Phoenix for its second year, offering exciting demo experiences for all ages across 1 million square feet of space at State Farm Stadium, April 12-13. With more brands, interactive exhibits and hands-on demos than ever before, attendees can explore the latest in EVs, from cars and trucks, to bikes, motorcycles, charging solutions and sustainable…
BELLINGHAM, Wash., April 02, 2025 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today unveiled its transformative Co-Sponsor Program — a bold evolution in how agents and commercial advisors collaborate, lead, and build wealth together at eXp. The announcement was made during eXpcon Montréal, where hundreds of agents and leaders from across Canada and the globe gathered for a three-day real estate conference. For the first time in company history, new agents and advisors joining eXp can now select both a Primary Sponsor…
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) — Finding the right appetite suppressant can be a game-changer for anyone struggling to manage cravings and control their weight. Over-the-counter (OTC) appetite suppressant pills offer a convenient, natural way to curb hunger and support weight loss—no prescription required. These dietary supplements are formulated with ingredients like fiber, capsaicinoids, and plant extracts, designed to reduce hunger, boost metabolism, and help you feel full longer. With so many options on the market, choosing the best OTC appetite suppressant can feel overwhelming. In this article, we’ll explore the strongest natural hunger suppressant available, helping you…
WILMINGTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) — LEDVANCE, a global leader in lighting innovation, is expanding its OPTI-SELECT™ Product Platform, reinforcing its commitment to flexibility, efficiency, and performance. The expanded lineup now includes a comprehensive range of indoor and outdoor lighting solutions, allowing users to adjust beam angles, color temperatures, and lumen outputs with the twist of a switch or the turn of a wrist—all without replacing lenses or reflectors. With OPTI-SELECT™ technology, lighting professionals can customize distribution patterns on-site, eliminating the hassle of multiple SKUs while enhancing installation speed, performance, and energy efficiency. This latest expansion includes Bollards,…
Dublin, April 02, 2025 (GLOBE NEWSWIRE) — The “Myocardial Infarction Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering.The Myocardial Infarction market is expected to reach US$ 3.64 billion by 2033 from US$ 2.14 billion in 2024, with a CAGR of 6.08% from 2025 to 2033 The market for myocardial infarction is mostly being driven by the rising incidence of coronary artery disorders, which cause plaque to accumulate on the inner walls of the arteries and decrease blood supply to the heart muscle. Furthermore, another important element driving increase is…
Denver, Co., April 02, 2025 (GLOBE NEWSWIRE) — As water utilities across the country navigate the complexities of lead service line replacement (LSLR) programs, an upcoming workshop at the American Water Works Association’s (AWWA) ACE25 conference will provide executive leaders and decision makers with the tools to plan for uncertainty and build resilient programs. CDM Smith experts Sandy Kutzing and Claire Baldwin are among the distinguished industry leaders who will help guide the discussion. Registration is currently open for this session, PCW05. The pre-conference workshop, Scenario Planning for Lead Service Line Replacement Programs, will take place on Sunday, June 8,…
RICHMOND, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) — Bob Smith is joining General Fusion as a strategic advisor. Smith brings more than 35 years of experience developing, scaling, and launching world-changing technologies, including spearheading new products and innovation in the aerospace industry at United Space Alliance, Sandia Labs, and Honeywell before serving as CEO of Blue Origin. He joins General Fusion as the company’s Lawson Machine 26 (LM26) fusion demonstration begins operations and progresses toward transformative technical milestones on the path to commercialization. “I’ve been watching the fusion energy industry closely for my entire career. Fusion is the last…
Dublin, April 02, 2025 (GLOBE NEWSWIRE) — The “Latin America NGS Market: Focus on Offering, Technology, Application, and End User – Analysis and Forecast, 2024-2034” report has been added to ResearchAndMarkets.com’s offering.The Latin America NGS market was valued at $268.04 million in 2024 and is anticipated to reach $597.20 million by 2034, witnessing a CAGR of 8.34% during the forecast period 2024-2034. The demand for NGS is driven by increasing applications in oncology, infectious disease research, and prenatal diagnostics. Next-generation sequencing (NGS) has transformed cancer diagnostics by enabling simultaneous analysis of multiple genes, facilitating precise tumor profiling, identifying actionable mutations,…